C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Price:
33.97
CNY
7.98%
Market Closed
Market Cap:
¥47.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
CN |
|
IG Design Group PLC
LSE:IGR
|
UK |
|
K
|
Kingkey Financial International Holdings Ltd
HKEX:1468
|
HK |
|
Wagners Holding Company Ltd
ASX:WGN
|
AU |
Multiples-Based Value
The Multiples-Based Value of one CSPC Innovation Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 33.97 CNY, CSPC Innovation Pharmaceutical Co Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CSPC Innovation Pharmaceutical Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
CSPC Innovation Pharmaceutical Co Ltd Competitors
CSPC Innovation Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
47.7B CNY | 22.1 | -197.9 | -85.5 | -85.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
855.1B USD | 13.1 | 41.4 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.7B USD | 6 | 27.3 | 17.5 | 22.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.6 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
229B GBP | 5.2 | 29.9 | 16.5 | 23.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228.1B CHF | 5 | 20.3 | 12.6 | 16.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.8B USD | 4.5 | 16 | 9.9 | 12.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.7 | 11.2 | 8.2 | 9.7 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.6B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
86.8B GBP | 2.7 | 15.2 | 8.2 | 10.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
